Zero Point Five Therapeutics

ZP5 is looking to cure the neglected diseases of the world. ZP5's first candidate (ZP5-9676) is a single-dose therapy intended to treat the major soil-worm transmitted diseases. Soil worm diseases have a disproportionate impact on children living in developing countries.

Investment Details

Portfolia Fund

Funding Round

Series A

Milestones

About the Founder

Joseph Amprey

‍

Amprey has been a professional in healthcare for over 23 years; he has also developed a career as an entrepreneur and venture capitalist. Joseph is utilizing his extensive background in science and business to create a child-friendly treatment for parasites.

‍

Real Investors. Real Outcomes.

“I have learned so much about leadership, financial well-being, and the power of connection from the amazing community of women at Portfolia.”

Peggy Northrop

CEO of Watermark and Former Editor-in-Chief of More Magazine, Connecticut

“I love the concept of being able to invest and collaborate with others, mitigating my own risk by investing in a portfolio. It lets me see more deals in the pipeline.”

Chantell Preston

Healthcare Executive, Houston, TX

“I joined because I was excited that the model was more like a mutual fund and offered exposure to so many companies and opportunities to further learning.”

Namrita Kapur

Fellow, Yale School of Management, Boston, MA